SCHEMBL26258291

SCHEMBL26258291

Cc1ccc2sc3cc(Cc4ccc5sc6ccccc6c5c4)ccc3c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
MAPT P10636 5/20 0.45
RAB9A P51151 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
HPGD P15428 1/20 0.45
GPR3 P46089 1/20 0.44
TDP1 Q9NUW8 3/20 0.40
L3MBTL1 Q9Y468 4/20 0.39
POLB P06746 1/20 0.39
KDM4E B2RXH2 2/20 0.38
CYP1A2 P05177 1/20 0.38
ATM Q13315 1/20 0.38
ROCK1 Q13464 1/20 0.38
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24677507 1.00 ALDH1A1 (0.45) ALDH1A1MAPTRAB9ASMN1; SMN2HPGD
SCHEMBL24750413 0.97 MAPT (0.45) ALDH1A1MAPTRAB9ASMN1; SMN2HPGD
SCHEMBL18823433 0.87 ROCK1 (0.48) ALDH1A1MAPTSMN1; SMN2HPGDTDP1
SCHEMBL6130182 0.87 GPR3 (0.54) ALDH1A1MAPTRAB9ASMN1; SMN2HPGD
SCHEMBL20804682 0.85 ALDH1A1 (0.41) ALDH1A1MAPTRAB9ASMN1; SMN2HPGD
SCHEMBL22373692 0.85 MAPT (0.38) ALDH1A1MAPTRAB9ASMN1; SMN2HPGD
SCHEMBL15785768 0.85 GPR3 (0.56) ALDH1A1MAPTRAB9ASMN1; SMN2HPGD
SCHEMBL257003 0.85 GPR3 (0.61) ALDH1A1MAPTRAB9ASMN1; SMN2HPGD
SCHEMBL25637489 0.84 MAPT (0.40) ALDH1A1MAPTRAB9ASMN1; SMN2HPGD
SCHEMBL19001866 0.84 SMN1; SMN2 (0.37) ALDH1A1MAPTRAB9ASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301183-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301183-A1 ORGANIC LIGHT EMITTING DEVICE CRY1, CRY2, CYP1A1 ALDH1A1 7/4885MAPT 1437/4885RAB9A 3024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.